Barclays Initiates Coverage On Edwards Lifesciences with Overweight Rating, Announces Price Target of $110

Benzinga · 2d ago
Barclays analyst Christopher Pasquale initiates coverage on Edwards Lifesciences (NYSE:EW) with a Overweight rating and announces Price Target of $110.